» Articles » PMID: 8897582

Management of Patients with Hemolytic Uremic Syndrome Demonstrating Severe Azotemia but Not Anuria

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1996 Oct 1
PMID 8897582
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There are no specific indications for dialysis in a patient with typical hemolytic uremic syndrome (D + HUS) who does not have anuria, hyperkalemia, volume overload, or severe acidemia. We managed five patients with D + HUS, aged 1.5-14 years, without dialysis despite marked azotemia, because they were not anuric and because they had none of the acid-base, fluid, or electrolyte perturbations that may have been indications for dialysis. Each had markedly elevated blood urea nitrogen (range 137-234 mg/dl) and serum creatinine concentrations (range 5.4-15.4 mg/dl). None was anuric and one was oliguric for 4 days. There were no complications and each recovered. We have reviewed the published literature on the use of dialysis in patients with D + HUS and have not found any guidelines that relate to the management of similar cases. It is our view that management of D + HUS patients without dialysis is appropriate when the patient is passing urine and the acid-base, serum electrolyte concentrations and fluid balances can be managed without dialysis.

Citing Articles

Hemolytic uremic syndrome: toxins, vessels, and inflammation.

Cheung V, Trachtman H Front Med (Lausanne). 2015; 1:42.

PMID: 25593915 PMC: 4292208. DOI: 10.3389/fmed.2014.00042.


HUS and TTP in Children.

Trachtman H Pediatr Clin North Am. 2013; 60(6):1513-26.

PMID: 24237985 PMC: 3972058. DOI: 10.1016/j.pcl.2013.08.007.


Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.

Thurman J, Marians R, Emlen W, Wood S, Smith C, Akana H Clin J Am Soc Nephrol. 2009; 4(12):1920-4.

PMID: 19820137 PMC: 2798880. DOI: 10.2215/CJN.02730409.


Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis.

Cobenas C, Alconcher L, Spizzirri A, Rahman R Pediatr Nephrol. 2007; 22(9):1343-7.

PMID: 17564728 DOI: 10.1007/s00467-007-0522-2.


Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury.

Trachtman H, Christen E, Cnaan A, Patrick J, Mai V, Mishra J Pediatr Nephrol. 2006; 21(7):989-94.

PMID: 16773412 DOI: 10.1007/s00467-006-0146-y.

References
1.
Habib R, Mathieu H, Royer P . [Hemolytic-uremic syndrome of infancy: 27 clinical and anatomic observations]. Nephron. 1967; 4(3):139-72. DOI: 10.1159/000179580. View

2.
Siegler R . Management of hemolytic-uremic syndrome. J Pediatr. 1988; 112(6):1014-20. DOI: 10.1016/s0022-3476(88)80239-7. View

3.
Argyle J, Hogg R, Pysher T, Silva F, Siegler R . A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol. 1990; 4(1):52-8. DOI: 10.1007/BF00858440. View

4.
Robson W, Leung A, Montgomery M . Causes of death in hemolytic uremic syndrome. Child Nephrol Urol. 1991; 11(4):228-33. View

5.
Welch T . Current management of selected childhood renal diseases. Curr Probl Pediatr. 1992; 22(10):432-51. DOI: 10.1016/0045-9380(92)90043-x. View